ATLASATLAS fair value
CN¥7.42
Below fair value · 26% discount
Range: CN¥5.24–CN¥11Fair valuePrice
Hainan Huluwa Pharmaceutical (605199.SHG)
Hainan Huluwa Pharmaceutical stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Shanghai Stock Exchange · China
CN¥5.49▼ -0.36%
Prices as of Oct 26, 2026 · CNY
Chance of rising in 1 month
51%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Hainan Huluwa Pharmaceutical in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Hainan Huluwa Pharmaceutical
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Hainan Huluwa Pharmaceutical's fair value at about CN¥7.42 per share (reasonable range: CN¥5.24 to CN¥11.10). At CN¥5.49, the stock trades 26% below it.
It is calculated with a discounted cash-flow model. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Hainan Huluwa Pharmaceutical a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CN¥5.22 and CN¥5.80; in 9 out of 10, between CN¥4.75 and CN¥6.37. Estimated annual volatility is 23%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- CN¥2.2B
- Market cap (USD)
- $336M
- 52-week high
- CN¥10.37
- 52-week low
- CN¥5.15
- Revenue (12 months)
- CN¥634M
- Gross margin
- 8.3%
- Operating margin
- -87.9%
- Net margin
- -63.6%
- Beta
- 0.34
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Hainan Huluwa Pharmaceutical sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks 605199.SHG has traded between CN¥5.15 and CN¥10.37. Today it is 47.1% below that high and 7% above its low.
Its beta is 0.34: it tends to move less than the market.
About the company
Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of digestive system, respiratory system, anti- infective, anti-virus and other fields in China.
Want to see everything about Hainan Huluwa Pharmaceutical?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Hainan Huluwa Pharmaceutical (605199.SHG) fair value?
About CN¥7.42 per share according to ATLAS (reasonable range: CN¥5.24 to CN¥11.10). With the stock at CN¥5.49, it is 26% below it.
What is the chance 605199.SHG goes up next month?
51%: close to a coin flip. In half of the simulated outcomes, 605199.SHG ends the month between CN¥5.22 and CN¥5.80.
How big is Hainan Huluwa Pharmaceutical and what is its P/E ratio?
Hainan Huluwa Pharmaceutical's market capitalization is CN¥2.2B. We do not show a P/E because it has no positive earnings to base one on.
How volatile is 605199.SHG?
ATLAS estimates annual volatility at 23%. In a typical month, half of the outcomes end between CN¥5.22 and CN¥5.80.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer